Moody Aldrich Partners LLC Alkermes Plc. Transaction History
Moody Aldrich Partners LLC
- $503 Million
- Q3 2024
A detailed history of Moody Aldrich Partners LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Moody Aldrich Partners LLC holds 84,907 shares of ALKS stock, worth $2.54 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
84,907
Previous 62,066
36.8%
Holding current value
$2.54 Million
Previous $1.5 Million
58.93%
% of portfolio
0.47%
Previous 0.32%
Shares
5 transactions
Others Institutions Holding ALKS
# of Institutions
362Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$872 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$569 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$390 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$379 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$275 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.92B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...